Ain Holdings Inc. · TSE:9627
Ain — FY4/22 2Q Earnings Presentation
23 slides from Ain's earnings presentation, Dec 9, 2021
Slide 1: FY4/22 2Q IR Presentation
FY4/22 2Q IR PRESENTATION December 2021
Slide 2: Results Overview
Results Overview © 2021 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 5.2% YoY and 3.4% against the plan due to increase of sales in dispensing pharmacy business, despite the impact of the COVID-19. Ordinary profit increased 35.6% YoY and 9.4% against the plan due to increase of sales. FY4/21 2Q FY4/22 2Q FY4/22 2Q YoY YoY Vs plan
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 6.9% YoY and 5.0% against the plan due to the recovery in prescription volume at existing stores and the contribution of stores opened in previous year. Segment profit increased 25.3% YoY and 12.8% against the plan due to increase of sa
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 4.6% YoY and declined 7.7% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of temporarily shorted opening hours and refrainment from going out under the spread o
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥48,704 million and shareholders’ equity ratio became 55.0%. We are maintaining a sound financial structure even during the COVID-19 outbreak. (¥ million) (¥ million) End-FY4/21 End-FY4/22 2Q Assets Liabilities Assets Liabilities Current assets 74,160 Current assets
Slide 7: Assets
Assets The balance of total assets increased ¥6,780 million from the end of the previous fiscal year due to increase of cash on hand and in banks. (¥ million) End-FY4/21 2Q End-FY4/21 End-FY4/22 2Q Change Cash on hand and in banks 54,616 55,271 58,692 +3,421 Notes and accounts receivable 11,953 13,4
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥4,707 million due to the increased purchases from new store openings and M&A. Short-term and long-term debt decreased ¥2,056 million due to repayment. (¥ million) End-FY4/21 2Q End-FY4/21 End-FY4/22 2Q Change Accounts payable 45,619 46,758 51,46
Slide 9: Consolidated C/F
Consolidated C/F Operating activities was ¥17,314 million due to active new store opening especially focus on large- scale store. Cash and cash equivalents at the end of the quarter were ample, up ¥4,116 million from the previous fiscal year. (¥ million) FY4/21 2Q FY4/22 2Q Change Net cash provided
Slide 10: Business Value Analysis
Business Value Analysis FY4/21 2Q FY4/21 FY4/22 2Q Change Shareholders’ equity ratio (%) 56.0 56.8 55.0 (1.0) Market value equity ratio (%) 129.6 105.6 112.3 (17.3) PER (times) 49.17 32.11 35.43 (13.74) EPS (¥) 74.24 189.04 94.68 +20.44 PBR (times) 2.31 1.86 2.05 (0.26) BPS (¥) 3,151.54 3,267.49 3,2
Slide 11: FY4/22 Plan (Consolidated)
FY4/22 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2022 of ¥315,000 million, increase 6.0% YoY and ordinary profit of ¥15,500 million, increase 22.5% YoY. FY4/20 FY4/21 FY4/22 YoY YoY （¥ million） results results plan change change(%) Net sales 292,615 297,3
Slide 12: Review
Review © 2021 AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Daily new COVID-19 cases across Japan
Daily new COVID-19 cases across Japan As of December 8, the number of domestic cases of the COVID-19 infection and deaths was 1,727,904 and 18,369, respectively. （people） 25,000 Aug.20 No. of daily positive cases 25,852 Paralympic 20,000 Aug.24－Sep.5 Olympic Jul.23－Aug.8 15,000 Declaration of the st
Slide 14: Review (YoY)
Review (YoY) Ordinary profit increased ¥1.6 billion due to increase of net sales in dispensing pharmacy business. Net sales +¥7.6 billion Ordinary profit +¥1.6 billion ¥152.9 billion ¥145.3 billion ¥6.1 billion Dispensing ¥4.5 billion Dispensing Dispensing Pharmacy Pharmacy Pharmacy +¥8.9 billion Di
Slide 15: Review (Vs plan)
Review (Vs plan) Net sales achieved the plan due to the steady increase of the dispensing pharmacy business, and ordinary profit increased ¥0.5 billion against the plan. Net sales +¥5.0 billion Ordinary profit +¥0.5 billion ¥152.9 billion ¥147.9 billion ¥6.1 billion Dispensing Dispensing Dispensing
Slide 16: Strategy
Strategy © 2021 AIN HOLDINGS INC. All Rights Reserved. 15
Slide 17: Strategy
Strategy Expansion of Top-line ■Dispensing Pharmacy Planning to open 80 pharmacies （Organic 40, M&A 40 ） ■Cosmetic and Drug Store Planning to open 15 stores Recruitment and training of human resources ■Planning to hire 600 newly graduated pharmacists（hired 613 new pharmacists in FY4/21） ■Newly assig
Slide 18: Opening: Top-line
Top-line The group opened 37 stores including M&A, and closed 8 stores during the FY4/22 2Q. ■ Plan FY4/22 2Q FY4/22 Plan Results Plan Dispensing Pharmacy 30 33 80 Hokkaido 13 12 40 125 Organic Opening M&A 17 21 40 Cosmetic and drug store 4 4 15 Koshinetsu 106 Tohoku Total 34 37 95 169 Hokuriku Disp
Slide 19: Recruiting of Pharmacists
Recruiting of Pharmacists In April 2021, new 613 pharmacists has joined our group. We aim to hire roughly the same number in fiscal 2022. ■ Transition of No. of national examination passers and new qualified pharmacists in AIN Group 2022 2013 2014 2015 2016 2017 2018 2019 2020 2021 （People） (Plan) N
Slide 20: Sustainability Management
Sustainability Management The group defined and disclosed important issues that should be addressed by the Group (materiality) in December 2020, and formulated a human rights policy in December 2021 as one of the initiatives for promoting respect of human rights. Materiality Related SDGs 1.Contribut
Slide 21: AINZ & TULPE
AINZ & TULPE AINZ & TULPE plan to open in FY4/22 15 stores Tokyo GRANDUO Tachikawa (Tokyo) (September, 2021) LACHIC FUKUOKA TENJIN SEVEN PARK AMAMI (Osaka) (October, 2021) (November, 2021） TOKYU SQUARE MINATOMIRAI Fukuoka (Kanagawa) (November, 2021) Ofuna（Kanagawa） AMU PLAZA KAGOSHIMA （July, 2021） K
Slide 22: FY4/22 Plan (Consolidated)
FY4/22 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2022 increase 6.0% and ordinary profit increase 22.5% YoY by opening new stores (80 dispensing pharmacies and 15 cosmetic and drug stores). FY4/20 FY4/21 FY4/22 YoY YoY （¥ million） results results plan chan
Slide 23: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha